Literature DB >> 10537164

Distinct expression of gelatinase A [matrix metalloproteinase (MMP)-2], collagenase-3 (MMP-13), membrane type MMP 1 (MMP-14), and tissue inhibitor of MMPs type 1 mediated by physiological signals during formation and regression of the rat corpus luteum.

K Liu1, J I Olofsson, P Wahlberg, T Ny.   

Abstract

The corpus luteum (CL) is a transient endocrine organ that secretes progesterone to support pregnancy. The CL is formed from an ovulated follicle in a process that involves extensive angiogenesis and tissue remodeling. If fertilization does not occur or implantation is unsuccessful, the CL will undergo regression, which involves extensive tissue degradation. Extracellular proteases, such as serine proteases and matrix metalloproteinases (MMPs), are thought to play important roles in both the formation and regression of the CL. In this study, we have examined the physiological regulation pattern and cellular distribution of messenger RNAs coding for gelatinase A (MMP-2), collagenase-3 (MMP-13), membrane type MMP 1 (MT1-MMP, MMP-14), and the major MMP inhibitor, tissue inhibitor of MMPs type 1 (TIMP-1) in the CL of adult pseudopregnant (psp) rat. Northern blot and in situ hybridization analyses revealed that gelatinase A messenger RNA was mainly expressed during luteal development, indicating that gelatinase A may be associated with the neovascularization and tissue remodeling that takes place during CL formation. Collagenase-3 had a separate expression pattern and was only expressed in the regressing CL, suggesting that this MMP may be related with luteal regression. MT1-MMP that in vitro can activate progelatinase A and procollagenase-3 was constitutively expressed during the formation, function, and regression of the CL and may therefore be involved in the activation of these MMPs. TIMP-1 was induced during both the formation and regression of the CL, suggesting that this inhibitor modulates MMP activity during these processes. To test whether the induction of collagenase-3 and TIMP-1 is coupled with luteal regression, we prolonged the luteal phase by performing hysterectomies, and induced premature luteal regression by treating the pseudopregnant rats with a PGF2alpha analog, cloprostenol. In both treatments, collagenase-3 and TIMP-1 were induced only after the serum level of progesterone had decreased, suggesting that collagenase-3 and TIMP-1 are induced by physiological signals, which initiate functional luteolysis to play a role in tissue degradation during structural luteolysis. In conclusion, our data suggest that gelatinase A, collagenase-3, and MT1-MMP may have separate functions during the CL life span: gelatinase A mainly takes part in CL formation, whereas collagenase-3 mainly takes part in luteal regression; MT1-MMP is constitutively expressed during the CL life span and may therefore serve as an in vivo activator of both gelatinase A and collagenase-3. TIMP-1 is up-regulated both during the formation and regression of the CL and may therefore regulate MMP activity during both processes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10537164     DOI: 10.1210/endo.140.11.7096

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  13 in total

1.  Reprolysin metalloproteases from Ixodes persulcatus, Rhipicephalus sanguineus and Rhipicephalus microplus ticks.

Authors:  Abid Ali; Lucas Tirloni; Masayoshi Isezaki; Adriana Seixas; Satoru Konnai; Kazuhiko Ohashi; Itabajara da Silva Vaz Junior; Carlos Termignoni
Journal:  Exp Appl Acarol       Date:  2014-04-01       Impact factor: 2.132

2.  Coordinated induction of extracellular proteolysis systems during experimental autoimmune encephalomyelitis in mice.

Authors:  T Teesalu; A E Hinkkanen; A Vaheri
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

3.  RUNX2 transcription factor regulates gene expression in luteinizing granulosa cells of rat ovaries.

Authors:  Eun-Sil Park; Anna-Karin Lind; Pernilla Dahm-Kähler; Mats Brännström; Martha Z Carletti; Lane K Christenson; Thomas E Curry; Misung Jo
Journal:  Mol Endocrinol       Date:  2010-03-02

4.  Differential expression of matrix metalloproteinases during stimulated ovarian recrudescence in Siberian hamsters (Phodopus sungorus).

Authors:  Trevor J Salverson; Greer E McMichael; Jonathan J Sury; Asha Shahed; Kelly A Young
Journal:  Gen Comp Endocrinol       Date:  2007-09-19       Impact factor: 2.822

5.  Regulation and function of tissue inhibitor of metalloproteinase (TIMP) 1 and TIMP3 in periovulatory rat granulosa cells.

Authors:  Feixue Li; Thomas E Curry
Journal:  Endocrinology       Date:  2009-04-23       Impact factor: 4.736

Review 6.  Significance of matrix metalloproteinases in the pathophysiology of the ovary and uterus.

Authors:  Toshiaki Endo; Tamotsu Kiya; Taeko Goto; Hirofumi Henmi; Kengo Manase; Hiroyuki Honnma; Tsuyoshi Baba; Shinichi Ishioka; Takuhiro Hayashi; Manabu Chida; Kazuyo Arima; Kiyohiro Yamazaki; Mika Kanaya; Atsushi Azumaguchi; Osamu Moriwaka; Hirofumi Kamiya; Tsuyoshi Saito
Journal:  Reprod Med Biol       Date:  2006-11-23

7.  Disrupted hyaluronan binding protein 1 (HABP1) expression: one of the key mediator for ovarian dysfunction in polycystic ovary rat.

Authors:  Mohammed Arif; Sonu Chand Thakur; Kasturi Datta
Journal:  Mol Cell Biochem       Date:  2014-10-10       Impact factor: 3.396

Review 8.  Metalloproteases in gonad formation and ovulation.

Authors:  Yong Zhu
Journal:  Gen Comp Endocrinol       Date:  2021-10-02       Impact factor: 2.822

9.  Ovarian matrix metalloproteinases are differentially regulated during the estrous cycle but not during short photoperiod induced regression in Siberian hamsters (Phodopus sungorus).

Authors:  Lisa A Vrooman; Kelly A Young
Journal:  Reprod Biol Endocrinol       Date:  2010-06-25       Impact factor: 5.211

10.  Temporal and spatial expression of tissue inhibitors of metalloproteinases 1 and 2 (TIMP-1 and -2) in the bovine corpus luteum.

Authors:  Bo Zhang; Marsha A Moses; Paul C W Tsang
Journal:  Reprod Biol Endocrinol       Date:  2003-11-07       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.